Interviews - Express Pharma

Direct-to-Retail will increasingly complement traditional pharma distribution

India is potentially on track to becoming a $300 billion bioeconomy

We can help our customers reach markets faster

Innovation has been at the heart of our growth journey

From Compliance to Commitment: How Piramal Pharma is Reimagining Sustainability in Pharma

Despite global volatility India’s pharma exports continue to demonstrate steady resilience

India needs to step up more as a strategic innovator in the global supply chain

We are well-aligned to capitalise on the CDMO opportunity

AI does not just make clinical trials faster; it makes them smarter

The use of FTWZs has risen by 20 to 25% every quarter after the pandemic